An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples